Burkhard Blank M.D.
Net Worth
Last updated:
What is Burkhard Blank M.D. net worth?
The estimated net worth of Dr. Burkhard Blank M.D. is at least $8,327,470 as of 1 Aug 2018. He has earned $582,160 from insider trading and has received compensation worth at least $7,745,310 in Acorda Therapeutics, Inc..
What is the salary of Burkhard Blank M.D.?
Dr. Burkhard Blank M.D. salary is $860,590 per year as Consultant in Acorda Therapeutics, Inc..
How old is Burkhard Blank M.D.?
Dr. Burkhard Blank M.D. is 70 years old, born in 1955.
What stocks does Burkhard Blank M.D. currently own?
As insider, Dr. Burkhard Blank M.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Acorda Therapeutics, Inc. (ACOR) | Consultant | 28,150 | $0 | $0 |
What does Acorda Therapeutics, Inc. do?
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS product for the treatment of acute migrain; rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York.
Burkhard Blank M.D. insider trading
Acorda Therapeutics, Inc.
Dr. Burkhard Blank M.D. has made 5 insider trades between 2016-2018, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 25,000 units of ACOR stock on 18 May 2018. As of 1 Aug 2018 he still owns at least 28,150 units of ACOR stock.
Acorda Therapeutics key executives
Acorda Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Burkhard Blank M.D. (70) Consultant
- Dr. Ron Cohen M.D. (69) Founder, Chief Executive Officer, Pres & Director
- Ms. Lauren M. Sabella (64) Chief Operating Officer